Flowers CR - Search Results

1

A phase 1 dose escalation study of bortezomib combined with rituximab, cyclophosphamide, doxorubicin, modified vincristine, and prednisone for untreated follicular lymphoma and other low-grade B-cell lymphomas.

Sinha R, Kaufman JL, Khoury HJ Jr, King N, Shenoy PJ, Lewis C, Bumpers K, Hutchison-Rzepka A, Tighiouart M, Heffner LT, Lechowicz MJ, Lonial S, Flowers CR. Sinha R, et al. Among authors: flowers cr. Cancer. 2012 Jul 15;118(14):3538-48. doi: 10.1002/cncr.26660. Epub 2012 Jan 3. Cancer. 2012. PMID: 22535574 Free article. Clinical Trial.

2

Refractory or relapsed Hodgkin's disease and non-Hodgkin's lymphoma: optimizing involved-field radiotherapy in transplant patients.

Kahn ST, Flowers CR, Lechowicz MJ, Hollenbach K, Johnstone PA. Kahn ST, et al. Among authors: flowers cr. Cancer J. 2005 Sep-Oct;11(5):425-31. doi: 10.1097/00130404-200509000-00011. Cancer J. 2005. PMID: 16259874

3

Results of a clinical phase I dose-escalation study of cytarabine in combination with fixed-dose vinorelbine, paclitaxel, etoposide and cisplatin for the treatment of relapsed/refractory lymphoma.

Lonial S, Arellano M, Hutcherson D, Langston A, Flowers C, Heffner LT, Winton E, Jo Lechowicz M, Waller EK. Lonial S, et al. Leuk Lymphoma. 2006 Oct;47(10):2155-62. doi: 10.1080/10428190600774923. Leuk Lymphoma. 2006. PMID: 17071490 Clinical Trial.

4

Value of PET restaging after chemotherapy for non-Hodgkin's lymphoma: implications for consolidation radiotherapy.

Kahn ST, Flowers C, Lechowicz MJ, Hollenbach K, Johnstone PA. Kahn ST, et al. Int J Radiat Oncol Biol Phys. 2006 Nov 15;66(4):961-5. doi: 10.1016/j.ijrobp.2006.07.1365. Int J Radiat Oncol Biol Phys. 2006. PMID: 17145526

5

Optimizing the timing of chemotherapy for mobilizing autologous blood hematopoietic progenitor cells.

Hicks ML, Lonial S, Langston A, Flowers C, Roback JD, Smith KJ, Mossavi Sai S, Teagarden D, Hamilton ES, Waller EK, Kaufman J. Hicks ML, et al. Transfusion. 2007 Apr;47(4):629-35. doi: 10.1111/j.1537-2995.2007.01164.x. Transfusion. 2007. PMID: 17381621

6

Racial differences in the incidence and outcomes for patients with hematological malignancies.

Flowers CR, Glover R, Lonial S, Brawley OW. Flowers CR, et al. Curr Probl Cancer. 2007 May-Jun;31(3):182-201. doi: 10.1016/j.currproblcancer.2007.01.005. Curr Probl Cancer. 2007. PMID: 17543947 Review. No abstract available.

7

Maintenance therapy in lymphoma.

Mihelic R, Kaufman J, Lonial S, Flowers C. Mihelic R, et al. Clin Lymphoma Myeloma. 2007 Sep;7(8):507-13. doi: 10.3816/clm.2007.n.034. Clin Lymphoma Myeloma. 2007. PMID: 18021467 Review.

8

Idiotype vaccine strategies for improving outcomes in follicular lymphoma.

Sinha R, Shenoy PJ, Flowers CR. Sinha R, et al. Among authors: flowers cr. Expert Opin Biol Ther. 2008 Aug;8(8):1213-23. doi: 10.1517/14712598.8.8.1213. Expert Opin Biol Ther. 2008. PMID: 18613772 Review.

9

Long-term progression-free survival after early autologous transplantation for mantle-cell lymphoma.

Murali S, Winton E, Waller EK, Heffner LT, Lonial S, Flowers C, Kaufman J, Arellano M, Lechowicz MJ, Mann KP, Khoury HJ, Langston AA. Murali S, et al. Bone Marrow Transplant. 2008 Oct;42(8):529-34. doi: 10.1038/bmt.2008.201. Epub 2008 Jul 14. Bone Marrow Transplant. 2008. PMID: 18622414

10

Incidence and outcomes of the peripheral T-cell lymphoma subtypes in the United States.

Abouyabis AN, Shenoy PJ, Lechowicz MJ, Flowers CR. Abouyabis AN, et al. Among authors: flowers cr. Leuk Lymphoma. 2008 Nov;49(11):2099-107. doi: 10.1080/10428190802455867. Leuk Lymphoma. 2008. PMID: 19021052

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

456 results

Search Page

Filters